{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:18:01Z","timestamp":1791483481971,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Korea Research Foundation Grant","award":["KRF-2007-E00108"],"award-info":[{"award-number":["KRF-2007-E00108"]}]},{"name":"Korea Health 21 R&D project, Ministry for Health, Welfare and Family Affairs, R.O.K.","award":["A084783"],"award-info":[{"award-number":["A084783"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.leukres.2009.11.008","type":"journal-article","created":{"date-parts":[[2009,12,24]],"date-time":"2009-12-24T09:10:24Z","timestamp":1261645824000},"page":"995-1001","source":"Crossref","is-referenced-by-count":11,"title":["Molecular characterization and prognostic significance of FLT3 in CML progression"],"prefix":"10.1016","volume":"34","author":[{"given":"Kyung Im","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juwon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Sung","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam-Hee","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung Kook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Gyoon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Soo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Mi","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.leukres.2009.11.008_bib1","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.leukres.2009.11.008_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.06.003","article-title":"Imatinib resistance in CML","volume":"274","author":"Volpe","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.leukres.2009.11.008_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/asheducation-2005.1.188","article-title":"Pathobiology of lymphoid and myeloid blast crisis and management issues","author":"Ilaria","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.leukres.2009.11.008_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(87)90754-6","article-title":"Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients","volume":"83","author":"Kantarjian","year":"1987","journal-title":"Am J Med"},{"issue":"17","key":"10.1016\/j.leukres.2009.11.008_bib5","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1073\/pnas.86.17.6783","article-title":"Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia","volume":"86","author":"Ahuja","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.leukres.2009.11.008_bib6","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood.V85.8.2013.bloodjournal8582013","article-title":"Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia","volume":"85","author":"Sill","year":"1995","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2009.11.008_bib7","first-page":"260","article-title":"Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progression","volume":"88","author":"Marktel","year":"2003","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.leukres.2009.11.008_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2141.2003.04500.x","article-title":"Flt3 mutations and leukaemia","volume":"122","author":"Kottaridis","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.leukres.2009.11.008_bib9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood.V87.3.1089.bloodjournal8731089","article-title":"Expression of the hematopoietic growth factor receptor FLT3 (STK-1\/Flk2) in human leukemias","volume":"87","author":"Carow","year":"1996","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.leukres.2009.11.008_bib10","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.2174\/1381612043384394","article-title":"Flt3 receptor tyrosine kinase as a drug target in leukemia","volume":"10","author":"Schmidt-Arras","year":"2004","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.leukres.2009.11.008_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2141.1997.3453159.x","article-title":"Bone marrow transplantation for chronic myeloid leukaemia: the effects of differing criteria for defining chronic phase on probabilities of survival and relapse","volume":"99","author":"Savage","year":"1997","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.leukres.2009.11.008_bib12","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V63.4.789.789","article-title":"Prognostic discrimination in \u201cgood-risk\u201d chronic granulocytic leukemia","volume":"63","author":"Sokal","year":"1984","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2009.11.008_bib13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/CAD.0b013e3280761a8a","article-title":"Combination of SK-7041, one of novel histone deacetylase inhibitors, and STI571-induced synergistic apoptosis in chronic myeloid leukemia","volume":"18","author":"Kim","year":"2007","journal-title":"Anticancer Drugs"},{"issue":"3","key":"10.1016\/j.leukres.2009.11.008_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1349-7006.2007.00717.x","article-title":"Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies","volume":"99","author":"Matsumura","year":"2008","journal-title":"Cancer Sci"},{"issue":"10","key":"10.1016\/j.leukres.2009.11.008_bib15","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1182\/blood.V80.10.2584.2584","article-title":"Expression of the FMS\/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages","volume":"80","author":"Birg","year":"1992","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2009.11.008_bib16","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3325\/cmj.2008.5.650","article-title":"Fms-like tyrosine kinase (FLT) 3 and FLT3 internal tandem duplication in different types of adult leukemia: analysis of 147 patients","volume":"49","author":"Peng","year":"2008","journal-title":"Croat Med J"},{"issue":"12","key":"10.1016\/j.leukres.2009.11.008_bib17","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nrd1579","article-title":"Strategies to overcome resistance to targeted protein kinase inhibitors","volume":"3","author":"Daub","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.leukres.2009.11.008_bib18","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood.V99.10.3530","article-title":"Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study","volume":"99","author":"Sawyers","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2009.11.008_bib19","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.biocel.2004.12.005","article-title":"FLT-3: a new focus in the understanding of acute leukemia","volume":"37","author":"Markovic","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"10.1016\/j.leukres.2009.11.008_bib20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00062752-200207000-00003","article-title":"Role of FLT3 in leukemia","volume":"9","author":"Gilliland","year":"2002","journal-title":"Curr Opin Hematol"},{"issue":"57","key":"10.1016\/j.leukres.2009.11.008_bib21","doi-asserted-by":"crossref","first-page":"8249","DOI":"10.1038\/sj.onc.1205029","article-title":"Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells","volume":"20","author":"Ohmine","year":"2001","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.leukres.2009.11.008_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1634\/stemcells.21-3-315","article-title":"Analysis of gene expression profiles in an imatinib-resistant cell line, KCL22\/SR","volume":"21","author":"Ohmine","year":"2003","journal-title":"Stem Cells"},{"issue":"8","key":"10.1016\/j.leukres.2009.11.008_bib23","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","author":"Radich","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"25","key":"10.1016\/j.leukres.2009.11.008_bib24","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1038\/sj.onc.1206620","article-title":"Chronic myelogenous leukemia molecular signature","volume":"22","author":"Nowicki","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.leukres.2009.11.008_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood-2005-05-2155","article-title":"Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML","volume":"107","author":"Yong","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2009.11.008_bib26","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.leukres.2009.03.044","article-title":"Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia","volume":"33","author":"Hoshino","year":"2009","journal-title":"Leuk Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521260900530X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521260900530X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T23:40:30Z","timestamp":1590450030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014521260900530X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S014521260900530X"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2009.11.008","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}